BARCELONA, Spain, July 1, 2026 /PRNewswire/ -- Vinamilk has been honored with 5 awards at the 2026 World Dairy Innovation Awards, one of the dairy industry's most prestigious international awards programs, held during the Global Dairy Congress in Barcelona, Spain, from 17th to 18th June 2026.
The recognition places Vinamilk among the world's leading dairy innovators and highlights the company's ability to anticipate and respond to rapidly evolving consumer needs. Vinamilk was also the only dairy brand from Southeast Asia to receive recognition at this year's awards, alongside major global dairy companies from Europe, North America and Oceania.
Click to Gallery
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
The World Dairy Innovation Awards celebrate organizations and products that are shaping the future of dairy through innovation, consumer relevance and industry leadership. This year, Vinamilk had 17 nominations shortlisted across 11 categories, reflecting the breadth of its innovation capabilities across nutrition, product development, production technology and consumer experience. The following products were honored with awards: Optimum A2 Pro+ won the Best Children's Dairy Product award; Sure Prevent Gold won the Best Life-stage Innovation award; Vinamilk Gelato Matcha Gotcha Ice Cream won the Best Ice Cream award; Vinamilk Fresh Milk 100% Flavored won the Best Flavored Dairy Drink award; Vinamilk Gelato Ice Cream won the Best Packaging Design award.
Mr. Richard Hall, Chairman of the Global Dairy Congress and the World Dairy Innovation Awards, noted that in more than 20 years of organizing the awards, he had never seen a company win 5 awards in a single edition. "That is really an incredible achievement. Vietnam is a large and dynamic market with significant consumer needs, but what stands out is how Vinamilk is innovating in ways that place it ahead of many companies and markets around the world."
The award comes at a time when the global dairy industry is undergoing significant transformation. Consumers are increasingly seeking nutrition solutions tailored to their lifestyles, health goals and individual needs, while also placing greater emphasis on convenience, transparency, and sustainability.
"Each stage of societal development creates new expectations for nutrition," said Mr. Nguyen Quang Tri, Marketing Executive Director of Vinamilk. "This recognition reflects our long-term commitment to innovation and our efforts to develop products and solutions that deliver meaningful value to consumers."
Beyond the award itself, Vinamilk's strong presence across multiple categories demonstrates its broader approach to innovation. The company's shortlisted products covered children's nutrition, specialized nutrition, liquid milk, yogurt, ice cream, packaging innovation and production technology, reflecting a strategy that extends beyond product formulation to encompass the entire consumer experience.
Mr. Ananda Roy, Senior Vice President – Thought Leadership Europe for Circana, a leading global market research and data analytics firm from the US and a member of the 2026 awards judging panel, stated, "Vinamilk is well positioned in the global market. To be a key player, all it needs to do is to continue investing in good products, packaging, the proposition and consumer communication, but beyond that, I am very confident about the success of this company."
For nearly 50 years, Vinamilk has evolved alongside changing consumer needs, from improving access to quality nutrition to developing increasingly specialized and personalized nutrition solutions. Today, the company continues to invest in research, innovation, and sustainable development to meet the demands of modern consumers and strengthen its position in international markets.
Those awards not only recognize Vinamilk's achievements today but also reinforce the company's ambition to contribute to the future development of the global dairy industry through continuous innovation and consumer-focused growth.
For more information, please visit www.vinamilk.com.vn/en.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Vinamilk Wins Big at the 2026 World Dairy Innovation Awards, Emerging as Southeast Asia's Only Award-Winning Dairy Brand
Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals
BANGKOK, July 1, 2026 /PRNewswire/ -- As global healthcare confronts the urgent challenge of antimicrobial resistance, Vitafoods Asia 2026, the region's premier nutraceutical trade show organised by Informa Markets, will showcase pioneering solutions that blend scientific rigour with natural innovation. Leading this charge are LiveSpo and Natural Remedies, two industry innovators presenting breakthrough technologies that address critical health burdens through advanced probiotics and clinical botanicals.
From the world's first probiotic nasal spray to next-generation botanical ingredients delivering unprecedented efficacy at minimal doses, these companies demonstrate how evidence-based natural solutions can reduce antibiotic dependence while supporting digestive health, respiratory wellness, and immunity. Their innovations represent the convergence of traditional wisdom and modern science, offering effective, sustainable alternatives to conventional treatments for global populations facing pressing health challenges.
LiveSpo: Pioneering a Future Without Antibiotics
LiveSpo, a biotechnology leader specialising in spore-based probiotics, is introducing world-first innovations that could transform how healthcare approaches antibiotic usage. The company is the first and only manufacturer globally to successfully produce high-quality, multi-species spore probiotics in liquid form, enabling clinically validated products across multiple applications.
At the forefront of LiveSpo's innovations is LiveSpo NAVAX, the world's first probiotic nasal spray designed to support respiratory health. Clinical trials demonstrate that NAVAX shortens RSV infection symptoms by one day and influenza symptoms by one to two days while increasing treatment effectiveness by 10–60% compared with physiological saline. The formulation reduces pro-inflammatory cytokines up to 3.6-fold more effectively in RSV cases and shortens pneumonia symptom duration by one day with 20–90% improved treatment efficacy.
LiveSpo's digestive health portfolio addresses the global burden of digestive disorders, which cause approximately 1.8 million deaths annually, with over 80% occurring in children under five years. LiveSpo Clausy, LiveSpo Colon, and LiveSpo Dia30 have been clinically shown to reduce antibiotic treatment duration by up to 25% when used alongside standard therapy and shorten persistent diarrhoea treatment by approximately three days. These formulations provide two-fold greater improvement in IBD-related symptom severity compared with control groups.
LiveSpo Kids specifically targets paediatric digestive wellness, demonstrating five-fold improvement in constipation management and eleven-fold enhancement in appetite compared to standard treatments. Clinical studies show the formulation increases weight by 0.3 kg per month in growing children while reducing pro-inflammatory cytokine IL-23 concentration nine-fold and increasing IgA ten-fold by day 28.
LiveSpo's unique spore probiotic technology provides 24-month stability in zone 4B with no cold storage required, ensuring product quality regardless of shipping route—a critical advantage for global distribution.
"I always believe that the most important thing for a scientist is how their research is applied in real life, how it can benefit and serve the community," said Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo. "Every year, there are about 5 million deaths worldwide caused by antibiotic resistance, mostly among children under 5 years old. The World Health Organisation has repeatedly warned about the global issue of drug resistance, but until now, WHO has not provided an effective tool to replace antibiotics. In 2013, LiveSpo Pharma successfully researched and developed the technology for producing Liquid Form, Multi-strains, High Concentration Spore Probiotics, which have the potential to gradually replace antibiotics."
He further added, "Vitafoods Asia provides the ideal platform for us to showcase our advanced spore probiotic technology to reputable partners across the region. As we pursue strategic regional expansion, this event allows us to connect with key industry players who share our vision of delivering innovative, science-backed probiotic solutions. We're eager to demonstrate how our pioneering liquid spore probiotic technology can help partners address critical health challenges while supporting our mission toward a future without antibiotics"
Natural Remedies: Transforming Nature into Clinical Excellence
Natural Remedies – Human Health Care brings decades of botanical expertise combined with cutting-edge science to Vitafoods Asia 2026. The company is showcasing its portfolio of clinically researched, standardised herbal ingredients designed for the global nutraceutical market.
The spotlight innovation is Ashwa.30™, a next-generation Ashwagandha ingredient powered by proprietary B.O.T™ (Bioactive Optimisation Technology). This breakthrough delivers benefits for energy, endurance, longevity, and stress management at just 30 mg per day, redefining efficacy in low-dose botanical supplementation.
Natural Remedies' comprehensive portfolio of clinically validated ingredients addresses multiple health categories. Holixer® is an award-winning ingredient clinically shown to provide better sleep experience, while BacoMind® enhances memory, focus, and recall. Gutgard® offers daily support for optimal digestive health, and Turmacin® provides water-soluble turmeric for superior joint health. The company's AP-Bio® / Kalmcold® offers trusted immune support solutions.
All ingredients combine traditional wisdom with rigorous scientific validation, featuring clinically proven efficacy, standardised bioactive profiles, low effective dosages, and global regulatory readiness. Products are registered with TGA, ANVISA, and KFDA, and comply with USA and EU standards, ensuring premium quality and trust worldwide. The company maintains ISO-certified R&D facilities and conducts rigorous clinical trials while practising responsible sourcing, biodiversity conservation, and greener energy solutions.
"The future of wellness lies in botanicals that combine traditional wisdom with modern scientific validation," said Dr. Suresh, Chief Business Officer, Natural Remedies. "Through innovations like B.O.T Technology, we are enabling the next generation of high-performance, science-backed botanical solutions."
He further added, "As a global leader in science-backed botanical ingredients, we see Vitafoods Asia as an essential trade event for connecting with partners and industry leaders who are shaping the future of health and wellness. This year, we're excited to showcase our latest innovations and demonstrate how clinically validated botanicals can empower brands to create truly differentiated, evidence-based products that meet evolving consumer demands for natural, effective health solutions."
Both companies serve nutraceutical, dietary supplement, functional food, beverage, and pharmaceutical sectors, with particular strength in active longevity and healthy ageing, stress and sleep management, cognitive performance, digestive and metabolic health, sports nutrition, immune support, and respiratory wellness.
For more information about Vitafoods Asia 2026, visit www.vitafoodsasia.com
About Vitafoods Asia
Vitafoods Asia is the leading nutraceutical event in Asia, bringing together industry professionals from across the globe to explore the latest trends, innovations, and opportunities in the nutraceutical and functional food sectors.
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
For media inquiries, please contact:
Gautam Jatwani
Senior Marketing Manager
Gautam.jatwani@informa.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
